These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [Abstract] [Full Text] [Related]
7. [Treatment of Crohn's disease by infliximab. About 20 cases]. Serghini M, Karoui S, Meknini M, Matri S, Kallel L, Fekih M, Boubaker J, Filali A. Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377 [Abstract] [Full Text] [Related]
8. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [Abstract] [Full Text] [Related]
12. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q, Hogezand RA, Lamers CB, Verspaget HW. Aliment Pharmacol Ther; 2004 Sep 01; 20(5):585-92. PubMed ID: 15339330 [Abstract] [Full Text] [Related]
13. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M. Digestion; 2008 Sep 01; 78(4):195-200. PubMed ID: 19122456 [Abstract] [Full Text] [Related]
15. [Indications and results of infliximab in Crohn's disease]. Karoui S, Boubaker J, Filali A. Tunis Med; 2004 Dec 01; 82(12):1057-63. PubMed ID: 15822505 [Abstract] [Full Text] [Related]
16. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Sandborn WJ, Hanauer SB. Am J Gastroenterol; 2002 Dec 01; 97(12):2962-72. PubMed ID: 12492177 [Abstract] [Full Text] [Related]
18. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Sands BE, Blank MA, Diamond RH, Barrett JP, Van Deventer SJ. Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1127-36. PubMed ID: 16611273 [Abstract] [Full Text] [Related]
19. Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy. de la Poza G, López-Sanroman A, Taxonera C, Marín-Jimenez I, Gisbert JP, Bermejo F, Opio V, Muriel A. J Crohns Colitis; 2012 Apr 15; 6(3):276-80. PubMed ID: 22405162 [Abstract] [Full Text] [Related]
20. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Domènech E, Hinojosa J, Nos P, Garcia-Planella E, Cabré E, Bernal I, Gassull MA. Aliment Pharmacol Ther; 2005 Dec 15; 22(11-12):1107-13. PubMed ID: 16305724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]